That would make sense. I had thought there was an increase in MRR that may not have flowed through in time for the quarterly but wanted to be conservative. If rollout was done early this quarter then $310 ARR gives $77.5k quarterly, which is in the ballpark of my $60k conservative estimate. Plus any additional increment from the 20 new RACs
Ann: PainChek Granted US Patent for Pain Assessment Invention, page-49
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.002(6.67%) |
Mkt cap ! $45.84M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.8¢ | $7.462K | 257.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1209083 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 60000 | 1 |
View Market Depth
| Last trade - 14.48pm 18/11/2024 (20 minute delay) ? |
| PCK (ASX) Chart |